Ignatius Press has published a comprehensive resource on the lifesaving therapy of abortion pill reversal. It is written by APR pioneer Dr. George Delgado.
READ MORE
There has been six mifepristone and APR-related studies published in the last three months. This post provides a summary and citation for each report.
READ MORE
A report in the European Journal of Contraception & Reproductive Health Care concludes that Depot MedroxyProgesterone Acetate (DMPA), a synthetic compound designed to mimic progesterone, may reverse the effects of mifepristone when used in a mifepristone-misoprostol abortion.
READ MORE
A randomized controlled trial published in the journal Reproduction found that progesterone supplementation after postovulatory mifepristone reduce changes in human endometrial gene expression. This research further supports the potential effectiveness of supplemental progesterone in reversing the effects of mifepristone when used for medication abortions.
READ MORE
New York Attorney General Letitia James has appealed a preliminary injunction by Judge John L. Sinatra, Jr, that blocks the AG from restricting Abortion Pill Reversal speech in the state of New York.
READ MORE
BMJ Sexual and Reproductive Health published a report that explored experiences of pain during medical abortion. The study found that over 40% of participants rated their pain as 8-10 on a maximum pain score (10 = worst pain). Also, 30% of participants stated that their actual versus expected experience of pain was "a lot more than expected."
READ MORE
Springer Nature published a book chapter entitled "Supporting Maternal Autonomy in Medical Abortion Pathways." The authors use the four pillars of bioethics (autonomy, justice, beneficence and non-maleficence) to argue that clinicians should provide progesterone to women who begin medical abortion and then change their mind.
READ MORE